Orrick advised Ananda Pharma plc on the admission to trading of its ordinary shares on the OTCQB Venture Market (OTCQB) in the U.S.

Orrick advised Willow, the FemTech leader that revolutionized the breast pumping experience, on its acquisition of Elvie.

In a case with major implications for innovators in the biopharma industry, an Orrick team has filed an innovators' amicus brief.

bluebird bio announced it will be acquired in a take private transaction by Beacon Parent Holdings, collaborating with Carlyle Group and SK Capital.

We’re excited to welcome Eric Hochstadt, who has played a pivotal role in shaping modern antitrust law.

Orrick’s 20 new partners strengthen the firm’s teams serving the tech, energy, finance and life sciences sectors.

Ipsen has agreed to sell its rare pediatric disease priority review voucher to a large global pharmaceutical company for $158 million.

Virios Therapeutics plans to combine with Wex Pharmaceuticals in an all-stock transaction to form a combined company called Dogwood Therapeutics.

Managing IP features Orrick IP partner Irena Royzman for her impact in shaping patent protections for life sciences and tech clients.

European investment firm Afinum has formed MedTech Laser Group through its investment in German company A.R.C. Laser and Israeli company G.N.S. ...

K Health Inc. has completed a $50 million equity funding round to advance its AI-driven primary care platform.

Welcome to a trio of leading FDA and healthcare regulatory advisors.